Cargando…

Kidney fibrosis: from mechanisms to therapeutic medicines

Chronic kidney disease (CKD) is estimated to affect 10–14% of global population. Kidney fibrosis, characterized by excessive extracellular matrix deposition leading to scarring, is a hallmark manifestation in different progressive CKD; However, at present no antifibrotic therapies against CKD exist....

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Rongshuang, Fu, Ping, Ma, Liang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10023808/ https://www.ncbi.nlm.nih.gov/pubmed/36932062 http://dx.doi.org/10.1038/s41392-023-01379-7

Ejemplares similares

Novel aspect of neprilysin in kidney fibrosis via ACSL4‐mediated ferroptosis of tubular epithelial cells
por: Lai, Weijing, et al.
Publicado: (2023)

Indispensable role of mitochondria in maintaining the therapeutic potential of curcumin in acute kidney injury
por: Li, Ling, et al.
Publicado: (2021)

Inhibition of Fatty Acid–Binding Protein 4 Attenuated Kidney Fibrosis by Mediating Macrophage-to-Myofibroblast Transition
por: Feng, Yanhuan, et al.
Publicado: (2020)

SKLB023 hinders renal interstitial fibrosis in obstructive nephropathy by interfering TGF-β1/Smad3 signaling
por: Feng, Yanhuan, et al.
Publicado: (2018)

Anti-Inflammatory Pyranochalcone Derivative Attenuates LPS-Induced Acute Kidney Injury via Inhibiting TLR4/NF-κB Pathway
por: Shi, Min, et al.
Publicado: (2017)

Therapeutic Approaches Targeting Proteostasis in Kidney Disease and Fibrosis
por: Chen, Jia-Huang, et al.
Publicado: (2021)

FFAR4 improves the senescence of tubular epithelial cells by AMPK/SirT3 signaling in acute kidney injury
por: Yang, Letian, et al.
Publicado: (2022)

Matrix Mechanics as Regulatory Factors and Therapeutic Targets in Hepatic Fibrosis
por: Chen, Guobao, et al.
Publicado: (2019)

Advances in stem cell therapy for peritoneal fibrosis: from mechanisms to therapeutics
por: Huang, Weiyan, et al.
Publicado: (2023)

TGF-β Inhibitors for Therapeutic Management of Kidney Fibrosis
por: Park, Cheol Ho, et al.
Publicado: (2022)

Mechanisms of Kidney Cell Pyroptosis in Chronic Kidney Disease and the Effects of Traditional Chinese Medicine
por: Ding, Baozhu, et al.
Publicado: (2021)

Analysis of biopsy-proven nephrotic syndrome in Tibetan patients
por: Huang, Rongshuang, et al.
Publicado: (2022)

Liver Fibrosis Resolution: From Molecular Mechanisms to Therapeutic Opportunities
por: Pei, Qiying, et al.
Publicado: (2023)

2-Methylquinazoline derivative 23BB as a highly selective histone deacetylase 6 inhibitor alleviated cisplatin-induced acute kidney injury
por: Hao, Yan, et al.
Publicado: (2020)

2-methylquinazoline derivative F7 as a potent and selective HDAC6 inhibitor protected against rhabdomyolysis-induced acute kidney injury
por: Liu, Jing, et al.
Publicado: (2019)

Recent Advances in Diabetic Kidney Diseases: From Kidney Injury to Kidney Fibrosis
por: Hung, Peir-Haur, et al.
Publicado: (2021)

Pharmacological Inhibition of Fatty Acid-Binding Protein 4 (FABP4) Protects Against Rhabdomyolysis-Induced Acute Kidney Injury
por: Huang, Rongshuang, et al.
Publicado: (2018)

Analysis of the relationship between Oxford classification, IgM deposition and multiple indexes and the adverse prognosis of patients with primary IgA nephropathy and related risk factors
por: Hao, Yan, et al.
Publicado: (2019)

Selective Histone Deacetylase 6 Inhibitor 23BB Alleviated Rhabdomyolysis-Induced Acute Kidney Injury by Regulating Endoplasmic Reticulum Stress and Apoptosis
por: Feng, Yuying, et al.
Publicado: (2018)

Proteomic Insights into Cardiac Fibrosis: From Pathophysiological Mechanisms to Therapeutic Opportunities
por: Qi, Ruiqiang, et al.
Publicado: (2022)

Natural Flavonoid Pectolinarigenin Alleviated Hyperuricemic Nephropathy via Suppressing TGFβ/SMAD3 and JAK2/STAT3 Signaling Pathways
por: Ren, Qian, et al.
Publicado: (2022)

Inflammation, Fibrosis and Cancer: Mechanisms, Therapeutic Options and Challenges
por: Wu, Bocheng, et al.
Publicado: (2022)

Therapeutic mechanism and clinical application of Chinese herbal medicine against diabetic kidney disease
por: Chen, Dan-Qian, et al.
Publicado: (2022)

Immunometabolism changes in fibrosis: from mechanisms to therapeutic strategies
por: Feng, Lixiang, et al.
Publicado: (2023)

Dysfunctional Inflammation in Cystic Fibrosis Airways: From Mechanisms to Novel Therapeutic Approaches
por: Ghigo, Alessandra, et al.
Publicado: (2021)

Understanding the Mechanism of Hepatic Fibrosis and Potential Therapeutic Approaches
por: Ahmad, Areeba, et al.
Publicado: (2012)

Precision renal medicine: a roadmap towards targeted kidney fibrosis therapies
por: Zeisberg, Michael, et al.
Publicado: (2015)

Autophagy as a Therapeutic Target for Chronic Kidney Disease and the Roles of TGF-β1 in Autophagy and Kidney Fibrosis
por: Ruby, Miss, et al.
Publicado: (2023)

New Insights into the Functions of MicroRNAs in Cardiac Fibrosis: From Mechanisms to Therapeutic Strategies
por: Zhao, Yuanyuan, et al.
Publicado: (2022)

Mechanisms of Chinese Herbal Medicines for Diabetic Nephropathy Fibrosis Treatment
por: Jiang, Tong, et al.
Publicado: (2022)

New insights into the pathogenesis and therapeutics of kidney fibrosis
por: Hou, Fan Fan, et al.
Publicado: (2014)

An update on renal fibrosis: from mechanisms to therapeutic strategies with a focus on extracellular vesicles
por: Wang, Cui, et al.
Publicado: (2023)

Tetramethylpyrazine: An Active Ingredient of Chinese Herbal Medicine With Therapeutic Potential in Acute Kidney Injury and Renal Fibrosis
por: Li, Jun, et al.
Publicado: (2022)

M2 macrophage polarization in systemic sclerosis fibrosis: pathogenic mechanisms and therapeutic effects
por: Hu, Mingyue, et al.
Publicado: (2023)

Promising therapeutic mechanism for Chinese herbal medicine in ameliorating renal fibrosis in diabetic nephropathy
por: Wang, Shengju, et al.
Publicado: (2023)

Pulmonary fibrosis from molecular mechanisms to therapeutic interventions: lessons from post-COVID-19 patients
por: Giacomelli, Chiara, et al.
Publicado: (2021)

Monocytes and macrophages: emerging mechanisms and novel therapeutic targets in pulmonary fibrosis
por: Perrot, Carole Y., et al.
Publicado: (2023)

Idiopathic pulmonary fibrosis and systemic sclerosis: pathogenic mechanisms and therapeutic interventions
por: Mattoo, Hamid, et al.
Publicado: (2021)

Imaging Techniques for the Study of Fibrosis in Atrial Fibrillation Ablation: From Molecular Mechanisms to Therapeutical Perspectives
por: De Sensi, Francesco, et al.
Publicado: (2021)

Pharmacological inhibition of fatty acid-binding protein 4 (FABP4) protects against renal ischemia-reperfusion injury
por: Shi, Min, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_anvjfbngibsv7b13qg64ab9nlo